Abstract
Background: Injecting drug use is associated with considerable morbidity and mortality. Estimates of the size of the population of people who inject drugs are critical to inform service planning and estimate disease burden due to injecting drug use. We aimed to estimate the size of the population of people who inject drugs in Australia. Methods: We applied a multiplier method which used benchmark data (number of people in opioid substitution therapy (OST) on a snapshot day in 2014) and multiplied it by a factor derived from the prevalence of current OST among people who inject drugs participating in the Australian Needle and Syringe Program Survey in 2014. Estimates of the total population of people who inject drugs were calculated in each state and territory and summed to produce a national estimate. We used the sex and age group distribution seen in datasets relating to people who inject drugs to derive sex-and age-stratified estimates, and calculated prevalence per 1000 population. Results: Between 68,000 and 118,000 people aged 15-64 years inject drugs in Australia. The population prevalence of injecting drug use was 6.0 (lower and upper uncertainty intervals of 4.3 and 7.6) per 1000 people aged 15-64 years. Injecting drug use was more common among men than women, and most common among those aged 35-44 years. Comparison of expected drug-related deaths based on these estimates to actual deaths suggest that these figures may be underestimates. Conclusions: These are the first indirect prevalence estimates of injecting drug use in Australia in over a decade. This work has identified that there are limited data available to inform estimates of this population. These estimates can be used as a basis for further work estimating injecting drug use in Australia.
Original language | English |
---|---|
Article number | 757 |
Journal | BMC Public Health |
Volume | 17 |
Issue number | 1 |
DOIs | |
Publication status | Published - 29 Sept 2017 |
Externally published | Yes |
Bibliographical note
Funding Information:This work was conducted as part of the Bloodborne viruses and sexually transmissible infections Research, Intervention and Strategic Evaluation (BRISE) program, funded by the NSW Ministry of Health. The funder had no role in the design of the study, collection, analysis or interpretation of data, or in writing the manuscript. RG, JG, GJD and LD are supported by Research Fellowships from the National Health and Medical Research Council. The National Drug and Alcohol Research Centre at the University of New South Wales is supported by funding from the Australian Government under the Substance Misuse Prevention and Service Improvements Grant Fund. The Kirby Institute is funded by the Australian Government Department of Health and Ageing.
Publisher Copyright:
© 2017 The Author(s).
Keywords
- Epidemiology
- Indirect prevalence estimation
- Multiplier methods
- People who inject drugs
- Population size